These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 27383536

  • 1. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
    Ying X, Wei K, Lin Z, Cui Y, Ding J, Chen Y, Xu B.
    Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X, Dong C, Law PT, Chan MT, Su Z, Wang S, Wu WK, Xu H.
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [Abstract] [Full Text] [Related]

  • 3. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
    Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew KP, Wu YL, Zhang S.
    Oncotarget; 2014 Dec 15; 5(23):12291-303. PubMed ID: 25460499
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
    Teng Y, Zhang Y, Qu K, Yang X, Fu J, Chen W, Li X.
    Oncotarget; 2015 Dec 01; 6(38):40799-814. PubMed ID: 26512921
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
    Zhang L, Li Z, Gai F, Wang Y.
    Mol Med Rep; 2015 Aug 01; 12(2):3107-14. PubMed ID: 25955305
    [Abstract] [Full Text] [Related]

  • 6. Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.
    Fan L, Lei H, Zhang S, Peng Y, Fu C, Shu G, Yin G.
    Theranostics; 2020 Aug 01; 10(13):5895-5913. PubMed ID: 32483426
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
    Cao Y, Shi H, Ren F, Jia Y, Zhang R.
    Exp Cell Res; 2017 Oct 01; 359(1):185-194. PubMed ID: 28754469
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
    Chong GO, Jeon HS, Han HS, Son JW, Lee YH, Hong DG, Park HJ, Lee YS, Cho YL.
    Cancer Genomics Proteomics; 2017 Oct 01; 14(2):137-141. PubMed ID: 28387653
    [Abstract] [Full Text] [Related]

  • 9. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH.
    Oncogene; 2012 Feb 09; 31(6):764-75. PubMed ID: 21725366
    [Abstract] [Full Text] [Related]

  • 10. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
    Zhou B, Xu H, Xia M, Sun C, Li N, Guo E, Guo L, Shan W, Lu H, Wu Y, Li Y, Yang D, Weng D, Meng L, Hu J, Ma D, Chen G, Li K.
    Front Med; 2017 Jun 09; 11(2):214-222. PubMed ID: 28470508
    [Abstract] [Full Text] [Related]

  • 11. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1.
    Niu K, Shen W, Zhang Y, Zhao Y, Lu Y.
    Gene; 2015 Dec 15; 574(2):330-6. PubMed ID: 26275944
    [Abstract] [Full Text] [Related]

  • 12. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
    Guo QY, Song JN, Chen YM, Yuan HN, Xue WS, Sun Y, Niu XL, Wang Y, Chen X.
    Med Oncol; 2024 May 14; 41(6):155. PubMed ID: 38744773
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S, Chen X, Xiu YL, Sun KX, Zhao Y.
    PLoS One; 2015 May 14; 10(5):e0125714. PubMed ID: 25933027
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
    Zhang J, Liu L, Sun Y, Xiang J, Zhou D, Wang L, Xu H, Yang X, Du N, Zhang M, Yan Q, Xi X.
    Oncotarget; 2016 May 03; 7(18):26516-34. PubMed ID: 27049921
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
    Jin M, Yang Z, Ye W, Xu H, Hua X.
    PLoS One; 2014 May 03; 9(8):e103965. PubMed ID: 25090005
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
    Bi L, Yang Q, Yuan J, Miao Q, Duan L, Li F, Wang S.
    Oncol Rep; 2016 Nov 03; 36(5):2563-2570. PubMed ID: 27571744
    [Abstract] [Full Text] [Related]

  • 17. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y, Dun Y, Zhou S, Huang XH.
    Biomed Pharmacother; 2017 Dec 03; 96():1216-1221. PubMed ID: 29239819
    [Abstract] [Full Text] [Related]

  • 18. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
    Lin M, Xia B, Qin L, Chen H, Lou G.
    DNA Cell Biol; 2018 May 03; 37(5):491-500. PubMed ID: 29485916
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
    Liu J, Jin S, Wang R.
    Mol Med Rep; 2017 Sep 03; 16(3):3379-3386. PubMed ID: 28713954
    [Abstract] [Full Text] [Related]

  • 20. Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro.
    Yan H, Wu W, Ge H, Li P, Wang Z.
    Int J Gynecol Cancer; 2015 Jul 03; 25(6):944-52. PubMed ID: 25962115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.